Results 171 to 180 of about 139,314 (301)

From Caffeine to Aspirin: Everyday Molecules as Triggers for Genetically Encoded Proximity Systems

open access: yesChemistry – A European Journal, EarlyView.
This Perspective article highlights how familiar dietary ingredients and over‐the‐counter (OTC) drugs (such as caffeine and its metabolites, SA, and aspirin) can be repurposed as clinically translatable chemical triggers for genetically encoded proximity systems.
Mingguang Cui   +5 more
wiley   +1 more source

<i>De Novo</i> Design in an M<sub>1</sub> Positive Allosteric Modulator Backup Program: The Discovery of VU6069863. [PDF]

open access: yesACS Med Chem Lett
Han C   +15 more
europepmc   +1 more source

Operationan Analysis of PLS 2.5 GeV Electron Linac Klystron-Modulator System

open access: yes, 2004
1
남상훈   +3 more
core  

Differential and state-dependent effects of the GluN2A-selective positive allosteric modulator GNE-5729 on executive functions. [PDF]

open access: yesNeuropsychopharmacology
Lauer J   +5 more
europepmc   +1 more source

Microtubule Destabilizing Kinesins: A Historical Perspective and Thoughts for the Future

open access: yesCytoskeleton, EarlyView.
ABSTRACT The microtubule cytoskeleton plays critical roles in multiple cellular processes such as mitotic spindle assembly and chromosome segregation. Cells contain a number of microtubule‐associated proteins that regulate microtubule dynamics both temporally and spatially in cells. The microtubule depolymerizing kinesins include members of the Kinesin‐
Claire E. Walczak
wiley   +1 more source

Discovery of VU6052959/BI'7927: A Selective mGlu<sub>3</sub> Positive Allosteric Modulator (PAM) from an Orthogonal Benzoxazine Chemotype. [PDF]

open access: yesACS Med Chem Lett
Jones CA   +30 more
europepmc   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant   +17 more
wiley   +1 more source

Cenobamate use in super‐refractory status epilepticus: A report of three cases

open access: yesEpileptic Disorders, EarlyView.
Abstract Objectives Super‐refractory status epilepticus (SRSE) is a neurological emergency with high morbidity and mortality. Cenobamate, a novel antiseizure medication, may be helpful in managing SRSE, but evidence is limited. Methods This retrospective case series reports the use of cenobamate as add‐on therapy in the management of three cases of ...
Marina Romozzi   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy